NCT00510484View on ClinicalTrials.gov

Study Investigating a Delayed-Release Pancrelipase in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis

PHASE3CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

March 31, 2008

Study Completion Date

March 31, 2008

Conditions
Cystic Fibrosis
Interventions
DRUG

Pancrelipase Delayed Release

24000 unit Capsule

DRUG

Placebo Comparator

Placebo

Trial Locations (23)

Unknown

Site 11, Long Beach

Site 10, Los Angeles

Site 13, San Francisco

Site 5, Miami

Site 4, Orlando

Site 1, Iowa City

Site 7, Louisville

Site 17, Boston

Site 8, Ann Arbor

Site 6, Minneapolis

Site 18, Long Branch

Site 16, Albuquerque

Site 19, Cincinnati

Site 12, Dayton

Site 2, Toledo

Site 14, Oklahoma City

Site 3, Hershey

Site 15, Philadelphia

Site 9, Nashville

Site 20, Petrofi

Site 21, Jerusalem

Site 22, Johannesburg

Site 23, Barcelona

All Listed Sponsors
lead

Solvay Pharmaceuticals

INDUSTRY

NCT00510484 - Study Investigating a Delayed-Release Pancrelipase in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis | Biotech Hunter | Biotech Hunter